GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (OTCPK:CPHRF) » Definitions » Median PS Value

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Median PS Value : $2.29 (As of Apr. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cipher Pharmaceuticals Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Cipher Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.832. Cipher Pharmaceuticals's 10-Year median PS Ratio is 2.7524. Therefore, the Median PS Value for today is $2.29.

As of today (2024-04-25), Cipher Pharmaceuticals's share price is $6.26. Cipher Pharmaceuticals's Median PS Value is $2.29. Therefore, Cipher Pharmaceuticals's Price to Median PS Value for today is 2.73.

The historical rank and industry rank for Cipher Pharmaceuticals's Median PS Value or its related term are showing as below:

CPHRF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22   Med: 0.36   Max: 2.93
Current: 2.73

During the past 13 years, the highest Price to Median PS Value of Cipher Pharmaceuticals was 2.93. The lowest was 0.22. And the median was 0.36.

CPHRF's Price-to-Median-PS-Value is ranked worse than
95.2% of 500 companies
in the Drug Manufacturers industry
Industry Median: 0.79 vs CPHRF: 2.73

Cipher Pharmaceuticals Median PS Value Historical Data

The historical data trend for Cipher Pharmaceuticals's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Median PS Value Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.38 3.25 2.55 2.15 2.37

Cipher Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 2.22 2.24 2.36 2.37

Competitive Comparison of Cipher Pharmaceuticals's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Price-to-Median-PS-Value falls into.



Cipher Pharmaceuticals Median PS Value Calculation

Cipher Pharmaceuticals's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.832*2.7524
=2.29

10-Year Median PS Ratio is 2.7524.
Cipher Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.832.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipher Pharmaceuticals  (OTCPK:CPHRF) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Cipher Pharmaceuticals's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=6.26/2.29
=2.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipher Pharmaceuticals Median PS Value Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (Cipher Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Headlines